RE:RE:RE:NewYours, mine or anyone's individual opinion is not relevant in comparison to the collective wisdom and opinion of the market as a whole. The Market that has brought the share price from a 52-week high of $117 to $13 equivalent to 89% shareholder's value destruction.
Look and listen to all the red flags and what The Market is telling us about them...on top of that the most important asset in any company is the personnel and when The Market losses confidence on Management that is a major big red flag and is very difficult to recover from.
Do your Due Dilligence and if anyone decides to put money on this one make sure it is money you're willing to lose.
Arizona546 wrote: A 40% drop today wasn't justified in my opinion. The valuation is ridiculous - even if they only do $6 EPS for 2016, that gives it a current P/E multiple of 1.67... Find me a another company so undervalued, nothing even comes close. Nothing really indicates they are going out of business and CXR could be bought by a larger pharma company to a much larger premium to this share price.
$13 s/p just way too oversold and undervalued, the earnings/news wasn't bad enough to justify dropping it to these levels I would say... This company is still generating great cash flow, managing its debt well, and will eventually find a more fair valuation once the fear subsides.